Please use this identifier to cite or link to this item:
Title: EZH2 and NF-KB Crosstalk in Breast Cancer
Keywords: EZH2, NFKB, breast cancer, ER, RelB
Issue Date: 26-Jun-2012
Citation: LEE SHUET THENG (2012-06-26). EZH2 and NF-KB Crosstalk in Breast Cancer. ScholarBank@NUS Repository.
Abstract: Both EZH2 and NF-kB contribute to aggressive breast cancer, yet whether the two oncogenic factors have functional crosstalk in breast cancer is unknown. Here, we uncover an unexpected role of EZH2 in conferring the constitutive activation of NF-kB target gene expression in ER-negative basal-like breast cancer cells. This function of EZH2 is independent of its histone methyltransferase activity but requires the physical interaction with RelA/RelB to promote the expression of NF-kB targets. Intriguingly, EZH2 acts oppositely in ER-positive luminal-like breast cancer cells and represses NF-kB target gene expression by interacting with ER and directing repressive histone methylation on their promoters. Thus, EZH2 functions as a double-facet molecule in breast cancers, either as a transcriptional activator or repressor of NF-kB targets, depending on the cellular context. These findings reveal an additional mechanism by which EZH2 promotes breast cancer progression and underscore the need for developing context-specific strategy for therapeutic targeting of EZH2 in breast cancers.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
HT081847H_LeeShuetTheng_PhD Thesis_with declaration (2).pdf2.61 MBAdobe PDF



Page view(s)

checked on Apr 8, 2019


checked on Apr 8, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.